Jacksonville Pharmaceuticals

Jacksonville Pharmaceuticals is a pharmaceutical company based in Jacksonville, Florida, that specializes in the development and commercialization of prescription generic drug products. The company was established to provide high-quality, cost-effective medication options to the healthcare market, focusing on a variety of therapeutic categories. In April 2016, Jacksonville Pharmaceuticals was acquired by PuraCap Pharmaceutical LLC, a move intended to bolster PuraCap's generic drug portfolio and expand its distribution footprint in the United States. Operating as a subsidiary, Jacksonville Pharmaceuticals leverages the extensive manufacturing and research resources of its parent company to bring generic products to market. The company primarily focuses on oral solid dosage forms and works closely with regulatory bodies to ensure compliance and safety.